Research output per year
Research output per year
Personal profile
Education
- MD, College of Medicine, National Yang-Ming University
Fingerprint
Dive into the research topics where Lu-Te Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis
Chen, C. N., Chang, L. T., Chen, C. H. & Tam, K. W., Feb 2022, In: Reproductive BioMedicine Online. 44, 2, p. 357-369 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Citations (Scopus) -
Author's Reply
Tsai, M. C., Chang, L. T. & Tam, K. W., Nov 2021, In: Journal of Minimally Invasive Gynecology. 28, 11, p. 1955-1956 2 p.Research output: Contribution to journal › Letter › peer-review
-
Comparison of High-Intensity Focused Ultrasound and Conventional Surgery for Patients with Uterine Myomas: A Systematic Review and Meta-Analysis
Tsai, M. C., Chang, L. T. & Tam, K. W., Oct 2021, In: Journal of Minimally Invasive Gynecology. 28, 10, p. 1712-1724 13 p.Research output: Contribution to journal › Review article › peer-review
8 Citations (Scopus) -
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. C., Wen, K. C., Sung, P. L., Chou, Y. T., Liew, P. L., Chen, L. Y., Huang, R. L., Lai, H. C. & Chang, L. T., Dec 2020, In: Journal of Ovarian Research. 13, 1, 143.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus)
Datasets
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor) & Chang, L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor) & Chang, L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset